BRAIN BrainCool AB (publ)
BrainCool AB (publ), a medical device company, together with its subsidiaries, engages in the development, marketing, and sale of medical cooling systems for the healthcare sector in Sweden. The company offers BrainCool system, a system to monitor and control a patient's temperature to anatomical zones for head/neck, thighs, and torso. It also offers RhinoChill system, a portable and battery-powered cooling product to spray liquid coolant for patient's nostrils with a catheter; Cooral system provides medical professionals a way to reduce the risk of oral mucositis; and IQool system, a temperature management system that monitors and controls a patient's temperature. In addition, the company provides products for medical cooling treatments for diseases, such as stroke, cardiac arrest, migraine, and oral mucositis. BrainCool AB (publ) was incorporated in 2010 and is based in Lund, Sweden.…
Industry Peers
Medical DevicesKey Statistics
About BrainCool (STO: BRAIN)
›
BrainCool (STO: BRAIN) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 8 employees.
The shares were at 1.162 SEK on 19 November 2026, up 94.0% over 52 weeks. Its 52-week range is 0.4105 SEK to 1.200 SEK: the price is 3.2% below the high and 183.1% above the low.
Its market capitalisation is 458.85M SEK.
BrainCool reports return on equity of -21.1%, an operating margin of -60.8% and revenue up 22.8% year over year.
It holds more cash than debt, a net cash position of 36.28M SEK. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health. One analyst covers the stock, with an average rating of Hold; their mean price target of 1.000 SEK is 13.9% below the current price.